期刊文献+

达英-35联合二甲双胍治疗多囊卵巢综合征的疗效探讨 被引量:3

To Investigate the Curative Effect of Diane-35 Combined with Metformin in Treatment of Polycystic Ovary Syndrome
下载PDF
导出
摘要 目的:分析达英-35与二甲双胍联合应用于多囊卵巢综合征治疗的临床效果。方法:随机抽选某院2015年3月~2016年4月收治的多囊卵巢综合征患者70例,分为对照组与治疗组,对照组患者在月经第5d开始行达英-35治疗,治疗组患者在对照组治疗的基础上联合二甲双胍治疗,观察两组患者治疗后的临床疗效。结果:治疗90d后,两组患者体重、LH、LDL-C、痤疮评分、T等方面均降低,其中治疗组改善效果更为明显,且治疗组患者血糖指数以及胰岛素抵抗指数均有所降低,两组患者停止用药后均出现撤退性出血、月经量与月经周期恢复正常,治疗组总有效率88.6%明显高于对照组总有效率68.6%,比较两者差异具有一定的显著性(P<0.05)。结论:达英-35与二甲双胍联合应用于多囊卵巢综合征治疗在一定程度上具有显著的临床效果。 Objective:To investigate the clinical efficacy of diane-35 combined metformin in treatment of polycystic ovary syndrome.Methods:70patients with polycystic ovary syndrome were selected randomly and divided into observation group and control group,35 cases in each group.Patients in the control group from the 5th day menstruation took diane-35(compound cyproterone acetate tablets).Patients in the treatment group were given metformin treatment on the basis of the treatment of the control group.The clinical efficacy of the two groups were observed after treatment.Results:After 90 days of treatment,body weight,LH,LDL-C,acne score,T,etc.of patients in the two groups of patients were reduced.The improvement effect was more obvious in the treatment group,and the blood glucose index and insulin resistance index were decreased in the treatment group.the two groups of patients after stopping the treatment had withdrawal bleeding,menstrual volume and cycle returned to normal.The total effect of 88.6% of the treatment group was significantly higher than that of 68.6% of control group.The difference between the two groups was significant(P0.05).Conclusion:Diane-35 combined with metformin in treatment of polycystic ovary syndrome has a significant clinical effect in a certain degree.
作者 张晓凤
出处 《数理医药学杂志》 2017年第8期1201-1203,共3页 Journal of Mathematical Medicine
关键词 达英-35 二甲双胍 多囊卵巢综合征 diane-35 metformin polycystic ovary syndrome
  • 相关文献

二级参考文献47

  • 1谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 2DIAZ M, CHACON M R, LOPEZ-BERMEJO A, et al. Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue[J]. J Clin Endocrinol Metab, 2012, 97(10): 3630-3638.
  • 3CINAR N, HARMANCI A, BAYRAKTAR M, et al. Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome[J]. Clin Endocrinol, 2013, 78(3): 379-384.
  • 4CHRISTAKOU C, KOLLIAS A, PIPERI C, et al. The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers[J]. Hormones, 2015, 13(4): 488-497.
  • 5GLINTBORG D, MUMM H, ALTINOK M L, et al. Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome[J]. J Endocrinol Invest, 2014, 37(8): 757-764.
  • 6GANIE M A, KHURANA M L, NISAR S, et al. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study[J]. J Clin Endocrinol Metab, 2013, 98(9): 3599-3607.
  • 7KAYA M G, CALAPKORUR B, KARACA Z, et al. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome[J]. Clin Endocrinol, 2012, 77(6): 885-892.
  • 8GODE F, KARAGOZ C, POSACI C, et al. Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate[J]. Arch Gynecol Obstet, 2011, 284(4): 923-929.
  • 9WILLIAMS R M, ONG K K, DUNGER D B. Polycystic ovarian syndrome during puberty and adolescence[J]. Mol Cell Endocrinol, 2013, 373(1/2): 61-67.
  • 10罗璐,王琼,周灿权,梁晓燕,方从,曾艳红,林雯青.达英-35联合二甲双胍预治疗对多囊卵巢综合征患者早期流产的影响[J].生殖与避孕,2009,29(9):609-612. 被引量:17

共引文献200

同被引文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部